--2024/Q4-- / 12.023M--
--2024/Q3-- / 8.749M--
Aug 13, 20242024/Q27.262M / 11.049M--
May 14, 20242024/Q125.377M / 18.881M--
Mar 21, 20242023/Q49.735M / 8.969M--
CA Stock MarketDetailed Quotes
FRX Fennec Pharmaceuticals Inc
- 6.260
- +0.110+1.79%
15min DelayMarket Closed Oct 4 16:00 ET
171.30MMarket Cap65.21P/E (TTM)
6.280High6.220Low13.15KVolume6.280Open6.150Pre Close82.06KTurnover15.43052wk High0.07%Turnover Ratio27.36MShares6.14052wk Low0.096EPS TTM117.31MFloat Cap391.500Historical HighLossP/E (Static)18.74MShs Float0.270Historical Low-0.795EPS LYR0.98%Amplitude--Dividend TTM-93.43P/B1Lot Size--Div YieldTTM
Fennec Pharmaceuticals Inc Key Stats
Fennec Pharmaceuticals Inc Q2 2024 Earnings Date
Currency：USDAug 13, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 11.05M | 7.26M | -3.79M |
| Miss Est. | +232.29% | +118.41% | -34.27% |
| EPS | -0.03 | -0.20 | -0.17 |
| Miss Est. | +85.76% | +4.76% | -568.90% |
Fennec Pharmaceuticals Inc Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data